Forecast for Vaccine Stocks After Coronavirus Pandemic Passes

Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.

Jun 17, 2022

More Videos

From Boeing to Meta: The Highs and Lows of Earnings Season (So Far)

With 40% of the S&P 500 reporting earnings this week, Cheddar correspondent Alison Kosik breaks down the highlights.

Not All A.I. Stocks Are Created Equally

With every company touting their new A.I. projects, one analyst cautions investors not all companies will grow as much as Nvidia.

Elon Musk Is the Only Tesla CEO ‘Who Can Ride it Out’

After an unsteady Q1 led to Tesla’s biggest sales drop in over a decade, one analyst says he still believes Elon Musk is the right leader.

The U.S. Just ‘Banned’ TikTok. Here’s What That Means for Your Account

President Biden signed a law requiring TikTok’s Chinese owner to sell the company. What happens next all comes down to the value of that algorithm.

2024 Bitcoin Halving: CEO Adam Sullivan Discusses the Impact

Bitcoin halving is a pivotal event in the cryptocurrency world. CEO Adam Sullivan from Core Scientific discusses its impact and more.

How Kore.AI Is Helping Businesses Use Artificial Intelligence

Kore.AI CEO, Raj Koneru, sits down with Kristen Scholer at the New York Stock Exchange to discuss his company and the future of artificial intelligence.

How Caitlin Clark Joining the WNBA Could Boost the League

The WNBA has lagged behind the NBA when it comes to popularity for years – but that could change if it converts NCAA viewers into passionate fans.

Caitlin Clark: Record-Breaking Game Changer

Caitlin Clark has made waves in women's college basketball. Her payday has sparked conversation. Is it fair? One person says yes...

Trending Now